Cor Therapeutics Inc. (CORR) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Mayo who wrote (306)	1/4/1999 1:23:00 PM
From: aknahow	Read Replies (2) of 712

I just read the 1997 hard copy of the annual report. It now is clear why there are so few post. Apparently only 350 shareholders as of March 1998. Since many of these are institutions, there are not many individuals that are interested in posting. I don't know how an institution can move into or out of this stock, without a big change in price. The report also surprised me. It seemed to be written for individuals not institutions. Big print, (2 pages with only 19 words), empty pages, many pictures and a lot of educational material on cardiac problems but very few hard facts about CORR. Even the notes did not elaborate on what type of drugs or cardiac problem was involved in the various collaboration agreements. An annual report is never cheap. Bet this one was very expensive and it does a terrible job. Still like the stock and again really appreciate the post to this board.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next